<DOC>
	<DOC>NCT00280657</DOC>
	<brief_summary>The purpose of the study is to determine safety and efficacy of an oral contraceptive in treating acne papulopustulosa.</brief_summary>
	<brief_title>Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa</brief_title>
	<detailed_description>The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer Schering Pharma AG, Germany.Bayer Schering Pharma AG, Germany is the sponsor of the trial.</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<criteria>Patients with mild to moderate facial papulopustular acne Contraindication against use of hormonal contraceptives</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Acne papulopustulosa</keyword>
</DOC>